title: [Breviscapine listed on progress of new varieties and dosage form research].
abstract: Breviscapine, a flavone glucuronide, is a cardiovascular medicine extracted from a Chinese herb Erigeron breviscapinus. Modern pharmacological research shows breviscapine has a therapeutic effect on cardiovascular diseases such as cerebral thrombus,cerebral ischemia hemiparesis and platelet aggregation et al. However, its poor water solubility and low bioavailability in vivo severely restrict the clinical application. In this article, we reviewed the marketing preparations of breviscapine and its research progress on the new dosage forms.
authors.forename: Li-Hua
authors.initials: LH
authors.lastname: Tian
authors.forename: Li-Zhong
authors.initials: LZ
authors.lastname: Zhao
authors.forename: Jia
authors.initials: J
authors.lastname: Gu
authors.forename: Jun
authors.initials: J
authors.lastname: Cai
authors.forename: Lei
authors.initials: L
authors.lastname: Yu
mesh_terms: D035843:Biomedical Research; D002545:Brain Ischemia / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage* / Q000191:economics; D005419:Flavonoids / Q000008:administration & dosage* / Q000191:economics; D006801:Humans
chemical_list: D004365:Drugs, Chinese Herbal; D005419:Flavonoids; C061097:breviscapine